Bio Special BioInvest

AusBioInvest 2023 marks beginning of Australia’s biggest week in biotech

 Australia’s biggest week is officially underway, with AusBioInvest 2023 kicking off today in Melbourne to an audience of investors and life sci...

 October 30, 2023 | News

CBC Healthcare Infrastructure Platform Secures US$875 Million with Mubadala Investment

  Following the initial close in November 2021 and the successful closing of four projects, CBC HIP continues to generate substantial pipeline, and t...

 October 23, 2023 | News

Leica Microsystems Unveils $60M Facility in Singapore for Advanced Microscopy Tech

Leica Microsystems (“Leica"), a global leader in microscopy and scientific instrumentation, today announced the official opening of its US$60 million...

 October 20, 2023 | News

GC Biopharma Signs Power Purchase Agreement with SK E&S

PPA is an electricity trading contract signed directly between a power generator and a customer company. Under this agreement, the company can purchase and...

 October 11, 2023 | News

Lynk Pharmaceuticals Secures 322 Million RMB in Series C2 Funding

This round of financing was jointly participated by the Shaoxing Binhai New Area Biomedical Industry Equity Investment Fund managed by China Grand Prosperi...

 September 22, 2023 | News

Cure Genetics and Frametact Strike $60M Deal for Familial Neurological Disease Gene Therapy

The partnership will leverage Cure Genetics' proprietary VELP™ platform to develop novel Adeno-Associated Virus (AAV) vectors for the treatment of fa...

 September 15, 2023 | News

New Zealand's Avasa Secures $1.55M in Oversubscribed Funding for Implantable Innovations

  The high interest in capital support affirms the investment community's confidence in Avasa's scientific approach to transforming procedures in rec...

 September 14, 2023 | News

Thyme Care Secures $60M Series B to Scale Cancer Care Beyond the Clinic

  Oncology care innovator streamlines a notoriously fragmented healthcare system, reducing gaps and barriers to care for chronically under supp...

 September 04, 2023 | News

Innovac Therapeutics Secures $18M Pre-A Funding for Lead Program Development

Innovac Therapeutics, an mRNA therapeutics company,  announced the completion of an $18 million Series Pre-A financing. The financ...

 September 04, 2023 | News

Epigenic Therapeutics Raises $32M for Breakthrough Epigenome Medicine Development

This round of financing will support the preclinical development and early clinical validation of two leading programs, discovery of future pipelines, expa...

 August 30, 2023 | News

Medtronic announces cash dividend for second quarter of fiscal year 2024

The board of directors of Medtronic plc (NYSE:MDT) on Thursday, August 17, 2023, approved an increase in the company's cash dividend for the seco...

 August 21, 2023 | News

Novo Holdings Joins $290m Fundraising for Sangon Biotech

Based in China, and with close to 30 years in operation, Sangon Biotech is a leading provider of life science tools in China. The Company offers ...

 August 18, 2023 | News

Neurophth Raises Almost $95M for Gene Therapy Trials in Series C+ Funding

Additionally, several prominent investment firms participated, including CMG-SDIC Capital, Silicon Paradise Asset Management and Yangtze River Industry Fun...

 August 14, 2023 | News

SK bioscience Announces Equity Investment in Novavax to Strengthen Strategic Partnership

SK bioscience makes a strategic equity investment in Novavax to respond to the endemic situation and strengthen their strategic partnership. SK bioscien...

 August 09, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close